Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-015323
Filing Date
2020-06-04
Accepted
2020-06-04 20:59:30
Documents
1
Period of Report
2020-06-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3951
  Complete submission text file 0000899243-20-015323.txt   5334
Mailing Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601
Business Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601 844-445-5704
XERIS PHARMACEUTICALS INC (Issuer) CIK: 0001346302 (see all company filings)

EIN.: 203352427 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1188 BROADWAY, SUITE 306 SOMERVILLE MA 02144
Business Address
BORMANN-KENNEDY BARBARA-JEAN ANNE (Reporting) CIK: 0001635065 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38536 | Film No.: 20944280